Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records

被引:5
作者
Campbell, Anne [1 ]
Bailey, Steffani R. [2 ]
Hoffman, Kim A. [3 ]
Ponce-Terashima, Javier [4 ]
Fankhauser, Katie [2 ]
Marino, Miguel [2 ,3 ]
McCarty, Dennis [3 ]
机构
[1] Queens Univ, Sch Social Sci Educ & Social Work, Belfast, ME, North Ireland
[2] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA
[3] Portland State Univ, Sch Publ Hlth, Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd CB669, Portland, OR 97230 USA
[4] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Substance use disorder; cannabis use disorder; electronic health records; psychiatric disorders; MAJOR DEPRESSIVE DISORDER; ANXIETY DISORDERS; MENTAL-HEALTH; RISK; METAANALYSIS; PREVALENCE; DEPENDENCE; PSYCHOSIS; MARIJUANA; SYMPTOMS;
D O I
10.1080/02791072.2020.1747665
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Data from a large network of community health centers connected via a single electronic health record (EHR) system examined associations between psychiatric disorders and documentation of a cannabis-related disorder among patients with reported cannabis use. Participants were adults who had at least one ambulatory visit at a clinic in three states between 1/1/2012 and 12/31/2016 and had either 1) a documented cannabis-related disorder indicated by an ICD-9/10 code on the problem list or encounter list or 2) documentation of cannabis use in the EHR social history section. Clinics included 101,405 patients with either cannabis use recorded in the social history of the EHR (n = 71,660) or a cannabis-related disorder documented in the encounter or problem list (n = 29,745). GEE logistic regression modeling estimated adjusted odds ratios (aOR). Odds of patients having cannabis-related disorder recorded on the encounter or problem list were higher for individuals with depression (aOR = 1.08, 95% CI: 1.04-1.13), anxiety (aOR = 1.16, CI: 1.11-1.21) and bipolar disorder (aOR = 1.16, CI: 1.10-1.23). A diagnosis of schizophrenia increased the odds of a cannabis-related disorder by 62% (aOR = 1.62, CI: 1.48- 1.78). Primary care providers should routinely screen for and document cannabis-related disorders and psychiatric disorders.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 39 条
[1]  
[Anonymous], 2000, AMERICAS HLTH CARE S, DOI DOI 10.17226/9612
[2]  
[Anonymous], 2017, HLTH EFF CANN CANN C
[3]  
[Anonymous], ANN REP STAT DRUGS P
[4]  
[Anonymous], 2018, Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068
[5]   Cannabis Use and Risk of Psychiatric Disorders Prospective Evidence From a US National Longitudinal Study [J].
Blanco, Carlos ;
Hasin, Deborah S. ;
Wall, Melanie M. ;
Florez-Salamanca, Ludwing ;
Hoertel, Nicolas ;
Wang, Shuai ;
Kerridge, Bradley T. ;
Olfson, Mark .
JAMA PSYCHIATRY, 2016, 73 (04) :388-395
[6]   Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders [J].
Brook, DW ;
Brook, JS ;
Zhang, CS ;
Cohen, P ;
Whiteman, M .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) :1039-1044
[7]  
Collins C, 2014, NEW ENGL J MED, V371, P879, DOI [10.1056/NEJMra1402309, 10.1056/NEJMc1407928]
[8]   The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study [J].
Di Forti, Marta ;
Quattrone, Diego ;
Freeman, Tom P. ;
Tripoli, Giada ;
Gayer-Anderson, Charlotte ;
Quigley, Harriet ;
Rodriguez, Victoria ;
Jongsma, Hannah E. ;
Ferraro, Laura ;
La Cascia, Caterina ;
La Barbera, Daniele ;
Tarricone, Ilaria ;
Berardi, Domenico ;
Szoke, Andrei ;
Arango, Celso ;
Tortelli, Andrea ;
Velthorst, Eva ;
Bernardo, Miguel ;
Del-Ben, Cristina Marta ;
Menezes, Paulo Rossi ;
Selten, Jean-Paul ;
Jones, Peter B. ;
Kirkbride, James B. ;
Rutten, Bart P. F. ;
de Haan, Lieuwe ;
Sham, Pak C. ;
van Os, Jim ;
Lewis, Cathryn M. ;
Lynskey, Michael ;
Morgan, Craig ;
Murray, Robin M. .
LANCET PSYCHIATRY, 2019, 6 (05) :427-436
[9]   Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study [J].
Di Forti, Marta ;
Marconi, Arianna ;
Carra, Elena ;
Fraietta, Sara ;
Trotta, Antonella ;
Bonomo, Matteo ;
Bianconi, Francesca ;
Gardner-Sood, Poonam ;
O'Connor, Jennifer ;
Russo, Manuela ;
Stilo, Simona A. ;
Marques, Tiago Reis ;
Mondelli, Valeria ;
Dazzan, Paola ;
Pariante, Carmine ;
David, Anthony S. ;
Gaughran, Fiona ;
Atakan, Zerrin ;
Iyegbe, Conrad ;
Powell, John ;
Morgan, Craig ;
Lynskey, Michael ;
Murray, Robin M. .
LANCET PSYCHIATRY, 2015, 2 (03) :233-238
[10]   Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users [J].
Di Forti, Marta ;
Sallis, Hannah ;
Allegri, Fabio ;
Trotta, Antonella ;
Ferraro, Laura ;
Stilo, Simona A. ;
Marconi, Arianna ;
La Cascia, Caterina ;
Marques, Tiago Reis ;
Pariante, Carmine ;
Dazzan, Paola ;
Mondelli, Valeria ;
Paparelli, Alessandra ;
Kolliakou, Anna ;
Prata, Diana ;
Gaughran, Fiona ;
David, Anthony S. ;
Morgan, Craig ;
Stahl, Daniel ;
Khondoker, Mizanur ;
MacCabe, James H. ;
Murray, Robin M. .
SCHIZOPHRENIA BULLETIN, 2014, 40 (06) :1509-1517